KredietR.T., BoeschotenE.W., ZuyderhoudtF.M.J., AriszL.The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.Clin Nephrol1987; 27: 51–5.
2.
NolphK.D., SorkinM., RubinJ.Continuousambulatory peritoneal dialysis: three-year experience at one center.Ann Intern Med1980; 92: 609–13.
3.
BoeschotenE.W., ZuyderhoudtF.M.J., KredietR.T., AriszL.Changes in weight and lipid concentrations during CAPD treatment.Perit Dial Bull1988; 8: 19–24.
4.
LameireN., MatthysD., MatthysE., BeheydtR.Effects of long-term CAPD on carbohydrate and lipid metabolism.Clin Nephrol1988; 30: S53–8.
5.
RamosJ.M., HeatonA., McGurkJ.G., WardM.K., KerrD.N.J.Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.Nephron1983; 35: 20–3.
LambE., Cat tellW.R., DawnayA.Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.Clin Sci1993; 84: 619–26.
8.
DobbieJ.W.New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis.Am J Kidney Dis1990; 15: 97–109.
9.
RippeB., StelinG., HaraldssonB.Computer simulations of peritoneal fluid transport in CAPD.Kidney Int1991; 40: 315–25.
10.
LukasG., BrindleS.D., GreengardP.The route of absorption of intra peritoneally administered compounds.J Pharm Exp Ther1971; 178: 562–6.
11.
KredietR.T., BoeschotenE.W., StruijkD.G., AriszL.Differences in the peritoneal transport of water, solutes and proteins between dialysis with two and with three-Iitre exchanges.Nephrol Dial Transplant1988; 2: 198–204.
12.
HeatonA., WardM.K., JohnstonD.G., NicholsonD.V., AlbertiK.G.M.M., KerrD.N.S.Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD).Clin Sci1984; 67: 121–30.
13.
WilliamsP.F., MarlissE.B., AnderssonG.H.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull1982; 2: 124–30.
14.
GoodshipT.H.J., LloydS., McKenzieP.W.Shortterm studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis.Clin Sci1987; 73: 471–8.
15.
MatthysE., DolkartR., LameireN.Extended use of glycerol-containing dialysate in diabetic CAPD patients.Perit Dial Bull1987; 7: 10–15.
16.
MatthysE., DolkartR., LameireN.Potential hazards of glycerol dialysate in diabetic CAPD patients.Perit Dial Bull1987; 7: 16–19.
17.
KredietR.T., StruijkD.G., KoomenG.C.M., HoekF J., AriszL.The disappearance of macromolecules from the peritoneal cavity during continuous ambulatory peritoneal dialysis (CAPD) is not dependent on molecular size.Perit Dial Int1990; 10: 147–52.
18.
KredietR.T., StruijkD.G., ZemelD., KoomenG.C.M., AriszL.The transport of macromolecules across the human peritoneum during CAPD. In: La GrecaG., RoncoC., FerianiM., ChiaramonteS., ConzP., eds. Peritoneal dialysis.Milano: Wichtig Editore, 1991: 61–9.
19.
StruijkD.G., BakkerJ.C., KredietR.T., KoomenG.C.M., StekkingerP., AriszL.Effect of intraperitoneal administration of two different batches of albumin solutions on peritoneal solute transport in CAPD patients.Nephrol Dial Transplant1991; 6: 198–202.
20.
MistryC.D., GokalR., MallickN.P.Ultrafiltration with an isosmotic solution during long-term peritoneal dialysis exchanges.Lancet1987; 2: 178–82.
21.
MistryC.D., O'DonoghueD.J., NelsonS., GokalR., BallardieF.W.Kinetic and clinical studies of β2 microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer.Nephrol Dial Transplant1990; 5: 513–19.
22.
MistryC.D., GokalR.Single daily overnight (12 h dwell) use of 7.5% glucose polymer (MW 18700; Mn 7300) + 0.35% glucose solution: a 3-month study.Nephrol Dial Transplant1993; 8: 443–7.
23.
ImholzA.L.T., BrownC.B., KoomenG.C.M., AriszL., KredietR.T.The effect of glucose polymers on water removal and protein clearances during CAPD. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1993; 9: 25–30.
24.
ElmanR.Amino-acid mixtures as parenteral protein food.Am J Med1948; 5: 760–74.
25.
HullR.L.Physiochemical considerations in intrave nous hyperalimentation.Am J Hosp Pharm1974; 31: 236–43.
26.
WyrickW.Rare complications with intravenous hyperosmotic alimentation.J Am Med Assoc1970; 211: 1697–8.
27.
SebanA., KonijnA.M., FreierS.Chemical and immunological properties of a protein hydrolysate formula.Am J Clin Nutr1977; 30: 840–6.
28.
GrimbleG.K., SilkD.B.A.Peptides in human nutrition.Nutr Res Rev1989; 2: 87–108.
29.
FentonS.S.A., JohnstonN., DelmoreT.Nutritional assessment of continuous ambulatory peritoneal dialysis.Trans Am Soc Artif Intern Organs1987; 33: 650–3.
30.
MarckmanP.Nutritional status of patients on hemodialysis and peritoneal dialysis.Clin Nephrol1988; 29: 75–8.
31.
LindholmB., BergströmJ.Nutritional aspects on peritoneal dialysis.Kidney Int1992; 38(Suppl): S165–71.
32.
KleinE., WardR.A., WilliamsT.E., FeldhoffP.W.Peptides as substitute osmotic agents for glucose in peritoneal dialysate.ASAIO Trans1986; 32: 550–3.
33.
MartisL., BurkeR., KleinE.Evaluation of a peptidebased solution for peritoneal dialysis.Perit Dial Int1993; 13(Suppl 2): S92–4.
34.
ImholzA.L.T., LameireN, FaictD., KoomenG.C.M., KredietR.T., MartisL.Evaluation of short chain polypeptides as osmotic agent in CAPD patients.Perit Dial Int, in press.
ImholzA.L. T., KoomenG.C.M., StruijkD.G., AriszL., KredietR.T.Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD.Kidney Int1993; 43: 1339–46.
37.
KredietR.T., ZemelD., ImholzA.L.T., KoomenG.C.M., StruijkD.G., AriszL.Indices of peritoneal permeability and surface area.Perit Dial Int1993; 13(Suppl 2): S31–4.
38.
ZemelD., KredietR.T., KoomenG.C.M., StruijkD.G., AriszL.Day-to-dayvariability of protein transport used as a method for analyzing peritoneal permeability in CAPD.Perit Dial Int1991; 11: 217–23.
39.
KredietR.T., ZemelD., StruijkD.G., KoomenG.C.M., AriszL.Individual characterization of the peritoneal restriction barrier to macromolecules. ln: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1991; 7: 15–20.
40.
StruijkD.G., KredietR.T., KoomenG.C.M.Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis.Nephron1991; 59: 213–20.
41.
ZemelD., ten BergeR.J.M., StruijkD.G., BloemenaE., KoomenG.C.M., KredietR.T.Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.Clin Nephrol1992; 37: 97–103.
42.
ZemelD., KoomenG.C.M., HartA.A.M., ten BergeR.J.M., StruijkD.G., KredietR.T.Relationship of TNFα, interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal followup of peritonitis in continuous ambulatory peritoneal dialysis.J Lab Clin Med1993; 122: 686–96.
43.
GoodshipT.H.I., LloydS., McKenzieP.W.Shortterm studies on the use of amino acids as osmotic agent in continuous ambulatory peritoneal dialysis.Clin Sci1987; 73: 471–8.
44.
YoungG.A., DibbleJ.B., TaylorA.E., KendallS., BrownjohnA.M.A longitudinal study on the effects of amino acidbased CAPD fluid on amino acid solution and protein losses.Nephrol Dial Transplant1989; 4: 900–5.
45.
SteinhauerH.B., Lubriek-BirknerI., KlutheR., BaumannG., SchollmeyerP.Effect of amino acid-based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.Am J Nephrol1992; 12: 61–7.
46.
ParkM.S., HeimbürgerO., BergströmJ., WaniewskiJ., WerynskiA., LindholmB.Peritoneal transport during dialysis with amino acid-based solutions.Perit Diallnt1993; 13: 280–8.
